A Post-authorization Safety Study to Evaluate the Safety of Multiple Myeloma Patients Treated with Ciltacabtagene Autoleucel

First published 18/10/2022

Last updated 03/06/2025

EU PAS number:

EUPAS49370

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

23May2024-REDACTED_Protocol-FD-68284528MMY4009-588202_946738 (1).pdf

English (3.87 MB - PDF)View document

Updated protocol

28May2025-Redacted_Protocol-Amend-1-FD-68284528MMY4009-588202 (4).pdf

First published: 28/05/2025

English (1.91 MB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

ENCePP Seal documents